BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17992117)

  • 1. Kinetic model of progression of cutaneous melanoma population.
    Gutkowicz-Krusin D; Rabinovitz HS
    Melanoma Res; 2007 Dec; 17(6):354-9. PubMed ID: 17992117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin melanomas.
    King R; Googe PB; Mihm MC
    Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics.
    Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM
    Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
    Elder DE; Gimotty PA; Guerry D
    Dermatol Ther; 2005; 18(5):369-85. PubMed ID: 16297012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
    Shaikh WR; Xiong M; Weinstock MA
    Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic signs in melanoma: state of the art.
    Lomuto M; Calabrese P; Giuliani A
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.
    Altamura D; Avramidis M; Menzies SW
    Arch Dermatol; 2008 Apr; 144(4):502-6. PubMed ID: 18427044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive malignant melanomas lacking competence for metastasis.
    Elder DE; Guerry D; Epstein MN; Zehngebot L; Lusk E; Van Horn M; Clark WH
    Am J Dermatopathol; 1984; 6 Suppl():55-61. PubMed ID: 6528943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma screening clinics: are we detecting more melanomas or reassuring the worried well?
    Weatherhead SC; Lawrence CM
    Br J Dermatol; 2006 Mar; 154(3):539-41. PubMed ID: 16445788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
    Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
    Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
    Montella A; Gavin A; Middleton R; Autier P; Boniol M
    Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.